Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
Medical Device

Boston Sci Makes Its Play In Transcatheter Valves With Sadra Acquisition

This article was originally published in The Gray Sheet

  • News

Executive Summary

Boston Scientific is entering the transcatheter aortic heart valve race in earnest with its deal, announced Nov. 19, to purchase the remainder of start-up firm Sadra Medical for up to $450 million.

You may also be interested in...



Edwards' TAVR Platforms Challenged In Boston Scientific Patent Suits

More patent litigation is emerging in the transcatheter aortic valve replacement space with two recent lawsuits alleging that Edwards Lifesciences' Sapien 3 TAVR device and delivery systems violated a total of nine patents held by Boston Scientific.

Research In Brief

Data and trial updates in cardiology, oncology and more.

Boston Scientific: Pipeline Will Aid Return To Growth By Year End

Potential growth drivers identified by the firm during its April 19 first-quarter earnings call include the Ingenio family of pacemakers and BSX-manufactured Promus Element everolimus-eluting stent system.

Table

View full table

Related Content

Medtech Insight Medtech Insight Medtech Insight Medtech Insight Medtech Insight Medtech Insight

Topics

Tags:
Medical Device
UsernamePublicRestriction

Register

MT029609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By